ATG12 and acute myeloid leukemia: Regarding FLT3-ITD AML, one published study has shown that inhibition of autophagy using shRNA targeting ATG12 or ATG5 can significantly reduce cell proliferation in FLT3-ITD cell lines or their tumorigenicity in a mouse model [23].